Immunology / Rheumatoid Arthritis
Indication
Rheumatoid Arthritis
Assets addressing this indication.
Total attributable cost
$32.7B
$24,068/patient
Drug spend
$13.4B
$9,885/patient
41% of total cost is drugs
All severities and treatment regimens (US estimate) · US